1.
PCV26 BELGIAN BUDGET IMPACT ANALYSES OF ALISKIREN (TEKTURNA/RASILEZ) IN HYPERTENSION
2.
3.
4.
PRS21 COST-EFFECTIVENESS ANALYSIS OF XOLAIR UNDER REAL LIFE CONDITIONS IN BELGIAN PATIENTS WITH SEVERE ALLERGIC ASTHMA
PRS36 XOLAIR QUALITY OF LIFE RESULTS AS MEASURED IN A BELGIAN OBSERVATIONAL STUDY IN PATIENTS WITH SEVERE ALLERGIC ASTHMA
PUK6 COST OF RENAL TRANSPLANTATION IN BELGIUM
PMD2 COST-EFFECTIVENESS ANALYSIS OF ACLASTA IN PAGET'S DISEASE OF BONE IN BELGIUM
PSK6 BELGIAN DRUG UTILISATION STUDY OF ELIDEL® IN ROUTINE PRACTICE IN ATOPIC DERMATITIS